Literature DB >> 26885057

The independent association of platelet parameters with overall survival in pancreatic adenocarcinoma receiving intensity-modulated radiation therapy.

Lei Wang1, Liming Sheng1, Peng Liu1.   

Abstract

BACKGROUND: Platelets are involved in multiple links of the process of thrombus formation and development. The aim of this study is to investigate the impact of pretreatment platelet parameters, such as plateletcrit (PCT), platelet mean distribution width (MDW), and mean platelet volume (MPV) in a cohort of patients with locally advanced pancreatic adenocarcinoma treated with a combination of chemotherapy and radiation therapy.
METHODS: A retrospective analysis was conducted of 163 locally advanced unresectable consecutive pancreatic adenocarcinoma patients who received chemoradiotherapy in Zhejiang cancer hospital from January 2009 to December 2011. The effects of platelet parameters on overall survival (OS) were assessed using Kaplan-Meier analysis. Independent prognostic factors were identified in the multivariate Cox analysis.
RESULTS: The median of the PC, PCT, MDW, MPV and CRP were 175×10(9), 20.0%, 14.0%, 10.8 fl and 7.0 mg/L, respectively. MDW was positively correlated with PC (r=0.156, P=0.047) and CRP (r=0.591, P<0.001). The median survival time of high MDW group was significantly worse than that of low MDW group (14.0 m Vs 11.0 m, P=0.008). Patients with high PCT were found to have shorter overall survival time (15.0 m Vs 11.0 m, P=0.018). Multivariate analysis indicated that MDW and N stage were two independent prognostic factors for overall survival (P<0.05). Patients with higher MDW had a 1.48-fold increased risk of death compared to those with low MDW.
CONCLUSIONS: MDW is an independent negative prognostic factor for overall survival in pancreatic adenocarcinoma patients.

Entities:  

Keywords:  Pancreatic adenocarcinoma; platelet; platelet parameters; prognosis

Year:  2015        PMID: 26885057      PMCID: PMC4723902     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma.

Authors:  Ismael Domínguez; Stefano Crippa; Sarah P Thayer; Yin P Hung; Cristina R Ferrone; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

2.  Lifestyle modification decreases the mean platelet volume in prehypertensive patients.

Authors:  Mehmet Yazici; Ahmet Kaya; Yasemin Kaya; Sinan Albayrak; Hakan Cinemre; Hakan Ozhan
Journal:  Platelets       Date:  2009-02       Impact factor: 3.862

Review 3.  Platelets and cancer-associated thrombosis.

Authors:  Gregory C Connolly; Richard P Phipps; Charles W Francis
Journal:  Semin Oncol       Date:  2014-04-24       Impact factor: 4.929

4.  The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.

Authors:  Haiyan Wang; Jinbiao Gao; Ming Bai; Rui Liu; Hongli Li; Ting Deng; Likun Zhou; Rubing Han; Shaohua Ge; Dingzhi Huang; Yi Ba
Journal:  Platelets       Date:  2013-09-03       Impact factor: 3.862

5.  Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer.

Authors:  Serta Kılınçalp; Fuat Ekiz; Omer Başar; Mehmet Raşit Ayte; Sahin Coban; Barış Yılmaz; Akif Altınbaş; Nurcan Başar; Bora Aktaş; Yaşar Tuna; Halil Erbiş; Engin Uçar; Elife Erarslan; Osman Yüksel
Journal:  Platelets       Date:  2013-03-28       Impact factor: 3.862

6.  Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.

Authors:  Xuegong Ma; Yingmei Wang; Hongna Sheng; Wenyan Tian; Zheng Qi; Fei Teng; Fengxia Xue
Journal:  J Obstet Gynaecol Res       Date:  2013-09-19       Impact factor: 1.730

7.  Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis.

Authors:  M G Alexandrakis; F H Passam; K Perisinakis; E Ganotakis; G Margantinis; D S Kyriakou; D Bouros
Journal:  Respir Med       Date:  2002-08       Impact factor: 3.415

8.  Impact of diabetes type II and chronic inflammation on pancreatic cancer.

Authors:  Dietmar Zechner; Tobias Radecke; Jonas Amme; Florian Bürtin; Ann-Christin Albert; Lars Ivo Partecke; Brigitte Vollmar
Journal:  BMC Cancer       Date:  2015-02-13       Impact factor: 4.430

Review 9.  The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors.

Authors:  Fabrice Cognasse; Kim Anh Nguyen; Pauline Damien; Archibald McNicol; Bruno Pozzetto; Hind Hamzeh-Cognasse; Olivier Garraud
Journal:  Front Immunol       Date:  2015-03-02       Impact factor: 7.561

10.  Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.

Authors:  Benjamin Kasenda; Annatina Bass; Dieter Koeberle; Bernhard Pestalozzi; Markus Borner; Richard Herrmann; Lorenz Jost; Andreas Lohri; Viviane Hess
Journal:  BMC Cancer       Date:  2014-09-29       Impact factor: 4.430

View more
  13 in total

1.  Hematological predictors and clinical outcomes in cardiac surgery.

Authors:  Bahar Aydınlı; Aslı Demir; Çiğdem Yıldırım Güçlü; Demet Bölükbaşı; E Utku Ünal; Rabia Koçulu; Gökçe Selçuk
Journal:  J Anesth       Date:  2016-06-09       Impact factor: 2.078

2.  Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis.

Authors:  Sheng Chen; Ning Na; Zhixiang Jian
Journal:  Onco Targets Ther       Date:  2017-12-21       Impact factor: 4.147

3.  The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer.

Authors:  Shiqing Cheng; Fuyan Han; Yong Wang; Yanqiu Xu; Teng Qu; Ying Ju; Zhiming Lu
Journal:  BMC Gastroenterol       Date:  2017-12-20       Impact factor: 3.067

4.  Prognostic value of mean platelet volume to plateletcrit ratio in patients with osteosarcoma.

Authors:  Bo Gou; Hong Cao; Xinghua Cheng; Wei Shang; Mingqing Xu; Wei Qian
Journal:  Cancer Manag Res       Date:  2019-02-18       Impact factor: 3.989

5.  Prognostic Values of Platelet-Associated Indicators in Resectable Lung Cancers.

Authors:  Jing-Jing Wang; Yin-Ling Wang; Xin-Xin Ge; Meng-Dan Xu; Kai Chen; Meng-Yao Wu; Fei-Ran Gong; Min Tao; Wen-Jie Wang; Liu-Mei Shou; Wei Li
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

6.  Prognostic Value and Clinicopathologic Features of Platelet Distribution Width in Cancer: A Meta-Analysis.

Authors:  Wenjie Xia; Wuzhen Chen; Jiangfeng Tu; Chao Ni; Kexin Meng
Journal:  Med Sci Monit       Date:  2018-10-06

7.  Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer.

Authors:  Xianjin Zhu; Yingping Cao; Pingxia Lu; Yanli Kang; Zhen Lin; Taisen Hao; Yanfang Song
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

8.  Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer.

Authors:  Jing-Mei Wang; Ying Wang; Yue-Qing Huang; Han Wang; Jie Zhu; Jian-Ping Shi; Yi-Fan Li; Jing-Jing Wang; Wen-Jie Wang
Journal:  Dose Response       Date:  2019-09-08       Impact factor: 2.658

9.  Preoperative plateletcrit is a Prognostic Biomarker for Survival in Patients with Non-Small Cell Lung Cancer.

Authors:  Joon Young Hur; Ha Yeon Lee; Hye Jung Chang; Cheon Woong Choi; Dae Hyun Kim; Wan Kyu Eo
Journal:  J Cancer       Date:  2020-02-25       Impact factor: 4.207

10.  The different associations between platelet distribution width and hypertension subtypes in males and females.

Authors:  Tingwei Li; Jiahui Jin; Zhaowei Meng; Wenjuan Zhang; Yongle Li; Xuefang Yu; Xin Du; Ming Liu; Qing Zhang; Ying Gao; Kun Song; Xing Wang; Yaguang Fan; Yan Wang
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.